HoneyBear Bioscines, Inc. is a Taiwan-based biotech company with a vision for global pharmaceutical market. We strive to develop new antibody technologies to bring novel antibody-drug conjugates (ADC) to the patients suffering from devastating cancers.

HoneyBear Bioscines has developed a unique site-specific conjugation platform “Co-Nectar” and a next generation ADC product pipeline.

Our business model includes ADC platform non-exclusive licensing and ADC product early exclusive licensing. Any co-development partnerships with biotech or pharmaceutical companies are also welcome.

HoneyBear Biosciences 嘉正生物科技股份有限公司

Org chart

Teams

Offices

HoneyBear Biosciences 嘉正生物科技股份有限公司

Org chart

Teams

Offices

Related companies